#WildImmunology #allegy
www.nature.com/articles/s41...
3
1
0
0
#WildImmunology #allegy
www.nature.com/articles/s41...
An allergy immunotherapy startup that received $119M in financing in 2022 is shutting down after two years. Antigen-driven tolerance induction is not well understood, and mouse models do not reliably match human responses.
#allegy
#immunology